nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0877	0.167	CbGbCtD
Perindopril—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0793	0.151	CbGbCtD
Perindopril—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0685	0.131	CbGbCtD
Perindopril—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0665	0.127	CbGbCtD
Perindopril—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0601	0.115	CbGbCtD
Perindopril—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0601	0.115	CbGbCtD
Perindopril—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0576	0.11	CbGbCtD
Perindopril—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0446	0.085	CbGbCtD
Perindopril—ACE—Metabolism of Angiotensinogen to Angiotensins—ENPEP—acquired immunodeficiency syndrome	0.00636	0.625	CbGpPWpGaD
Perindopril—ACE—nerve—acquired immunodeficiency syndrome	0.0051	0.0856	CbGeAlD
Perindopril—ACE—endothelium—acquired immunodeficiency syndrome	0.00434	0.0729	CbGeAlD
Perindopril—ACE—blood plasma—acquired immunodeficiency syndrome	0.00385	0.0647	CbGeAlD
Perindopril—BCHE—blood plasma—acquired immunodeficiency syndrome	0.00285	0.0478	CbGeAlD
Perindopril—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.00207	0.0347	CbGeAlD
Perindopril—SLC15A2—retina—acquired immunodeficiency syndrome	0.00184	0.0309	CbGeAlD
Perindopril—SLC15A1—vagina—acquired immunodeficiency syndrome	0.00183	0.0307	CbGeAlD
Perindopril—ACE—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00167	0.164	CbGpPWpGaD
Perindopril—ACE—lymphoid tissue—acquired immunodeficiency syndrome	0.0015	0.0252	CbGeAlD
Perindopril—ACE—digestive system—acquired immunodeficiency syndrome	0.00148	0.0249	CbGeAlD
Perindopril—ACE—blood—acquired immunodeficiency syndrome	0.00141	0.0237	CbGeAlD
Perindopril—BCHE—skin of body—acquired immunodeficiency syndrome	0.00137	0.023	CbGeAlD
Perindopril—ACE—bone marrow—acquired immunodeficiency syndrome	0.00137	0.0229	CbGeAlD
Perindopril—ACE—spinal cord—acquired immunodeficiency syndrome	0.00136	0.0228	CbGeAlD
Perindopril—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.00136	0.0228	CbGeAlD
Perindopril—ACE—lung—acquired immunodeficiency syndrome	0.00124	0.0208	CbGeAlD
Perindopril—SLC15A2—blood—acquired immunodeficiency syndrome	0.00123	0.0207	CbGeAlD
Perindopril—SLC15A2—spinal cord—acquired immunodeficiency syndrome	0.00119	0.0199	CbGeAlD
Perindopril—ACE—nervous system—acquired immunodeficiency syndrome	0.00115	0.0193	CbGeAlD
Perindopril—SLC15A2—vagina—acquired immunodeficiency syndrome	0.00114	0.0192	CbGeAlD
Perindopril—ACE—central nervous system—acquired immunodeficiency syndrome	0.0011	0.0185	CbGeAlD
Perindopril—BCHE—digestive system—acquired immunodeficiency syndrome	0.00109	0.0184	CbGeAlD
Perindopril—SLC15A2—lung—acquired immunodeficiency syndrome	0.00108	0.0181	CbGeAlD
Perindopril—BCHE—blood—acquired immunodeficiency syndrome	0.00104	0.0175	CbGeAlD
Perindopril—BCHE—bone marrow—acquired immunodeficiency syndrome	0.00101	0.017	CbGeAlD
Perindopril—BCHE—spinal cord—acquired immunodeficiency syndrome	0.001	0.0169	CbGeAlD
Perindopril—SLC15A2—nervous system—acquired immunodeficiency syndrome	0.000999	0.0168	CbGeAlD
Perindopril—BCHE—vagina—acquired immunodeficiency syndrome	0.000967	0.0162	CbGeAlD
Perindopril—SLC15A2—central nervous system—acquired immunodeficiency syndrome	0.000962	0.0162	CbGeAlD
Perindopril—BCHE—lung—acquired immunodeficiency syndrome	0.000914	0.0154	CbGeAlD
Perindopril—ACE—brain—acquired immunodeficiency syndrome	0.000876	0.0147	CbGeAlD
Perindopril—BCHE—nervous system—acquired immunodeficiency syndrome	0.000847	0.0142	CbGeAlD
Perindopril—ACE—lymph node—acquired immunodeficiency syndrome	0.000846	0.0142	CbGeAlD
Perindopril—BCHE—central nervous system—acquired immunodeficiency syndrome	0.000815	0.0137	CbGeAlD
Perindopril—SLC15A2—brain—acquired immunodeficiency syndrome	0.000764	0.0128	CbGeAlD
Perindopril—ABCB1—retina—acquired immunodeficiency syndrome	0.000743	0.0125	CbGeAlD
Perindopril—SLC15A2—lymph node—acquired immunodeficiency syndrome	0.000738	0.0124	CbGeAlD
Perindopril—BCHE—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.000671	0.066	CbGpPWpGaD
Perindopril—BCHE—brain—acquired immunodeficiency syndrome	0.000647	0.0109	CbGeAlD
Perindopril—BCHE—lymph node—acquired immunodeficiency syndrome	0.000625	0.0105	CbGeAlD
Perindopril—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000528	0.00887	CbGeAlD
Perindopril—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000522	0.00876	CbGeAlD
Perindopril—ABCB1—blood—acquired immunodeficiency syndrome	0.000497	0.00835	CbGeAlD
Perindopril—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000481	0.00808	CbGeAlD
Perindopril—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000479	0.00804	CbGeAlD
Perindopril—ABCB1—vagina—acquired immunodeficiency syndrome	0.000461	0.00774	CbGeAlD
Perindopril—ABCB1—lung—acquired immunodeficiency syndrome	0.000436	0.00732	CbGeAlD
Perindopril—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000403	0.00678	CbGeAlD
Perindopril—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000388	0.00653	CbGeAlD
Perindopril—ACE—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000316	0.031	CbGpPWpGaD
Perindopril—ABCB1—brain—acquired immunodeficiency syndrome	0.000308	0.00518	CbGeAlD
Perindopril—ABCB1—lymph node—acquired immunodeficiency syndrome	0.000298	0.00501	CbGeAlD
Perindopril—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000215	0.00053	CcSEcCtD
Perindopril—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000215	0.00053	CcSEcCtD
Perindopril—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000529	CcSEcCtD
Perindopril—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000529	CcSEcCtD
Perindopril—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000529	CcSEcCtD
Perindopril—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000529	CcSEcCtD
Perindopril—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000214	0.000527	CcSEcCtD
Perindopril—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000527	CcSEcCtD
Perindopril—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000214	0.000527	CcSEcCtD
Perindopril—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000213	0.000526	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000213	0.000525	CcSEcCtD
Perindopril—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000213	0.000524	CcSEcCtD
Perindopril—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000212	0.000523	CcSEcCtD
Perindopril—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000212	0.000523	CcSEcCtD
Perindopril—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000523	CcSEcCtD
Perindopril—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000212	0.000523	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000212	0.000522	CcSEcCtD
Perindopril—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000212	0.000522	CcSEcCtD
Perindopril—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000212	0.000521	CcSEcCtD
Perindopril—Pain—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000519	CcSEcCtD
Perindopril—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000211	0.000519	CcSEcCtD
Perindopril—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.00021	0.000518	CcSEcCtD
Perindopril—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.00021	0.000518	CcSEcCtD
Perindopril—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.00021	0.000517	CcSEcCtD
Perindopril—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.00021	0.000516	CcSEcCtD
Perindopril—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.000516	CcSEcCtD
Perindopril—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000209	0.000516	CcSEcCtD
Perindopril—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000209	0.000515	CcSEcCtD
Perindopril—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000209	0.000515	CcSEcCtD
Perindopril—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000209	0.000514	CcSEcCtD
Perindopril—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000513	CcSEcCtD
Perindopril—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000208	0.000513	CcSEcCtD
Perindopril—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000513	CcSEcCtD
Perindopril—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000512	CcSEcCtD
Perindopril—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000512	CcSEcCtD
Perindopril—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000208	0.000511	CcSEcCtD
Perindopril—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000511	CcSEcCtD
Perindopril—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000207	0.000511	CcSEcCtD
Perindopril—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.000509	CcSEcCtD
Perindopril—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000509	CcSEcCtD
Perindopril—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000509	CcSEcCtD
Perindopril—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000509	CcSEcCtD
Perindopril—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000206	0.000507	CcSEcCtD
Perindopril—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000507	CcSEcCtD
Perindopril—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000506	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000205	0.000506	CcSEcCtD
Perindopril—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000205	0.000504	CcSEcCtD
Perindopril—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.000503	CcSEcCtD
Perindopril—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000501	CcSEcCtD
Perindopril—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000203	0.0005	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.0005	CcSEcCtD
Perindopril—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000499	CcSEcCtD
Perindopril—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000202	0.000498	CcSEcCtD
Perindopril—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000498	CcSEcCtD
Perindopril—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000202	0.000498	CcSEcCtD
Perindopril—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000202	0.000498	CcSEcCtD
Perindopril—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000497	CcSEcCtD
Perindopril—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000496	CcSEcCtD
Perindopril—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000201	0.000496	CcSEcCtD
Perindopril—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000496	CcSEcCtD
Perindopril—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000496	CcSEcCtD
Perindopril—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000201	0.000495	CcSEcCtD
Perindopril—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000495	CcSEcCtD
Perindopril—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000201	0.000494	CcSEcCtD
Perindopril—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000201	0.000494	CcSEcCtD
Perindopril—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000493	CcSEcCtD
Perindopril—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000492	CcSEcCtD
Perindopril—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.0002	0.000492	CcSEcCtD
Perindopril—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.00049	CcSEcCtD
Perindopril—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00049	CcSEcCtD
Perindopril—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000199	0.00049	CcSEcCtD
Perindopril—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000199	0.00049	CcSEcCtD
Perindopril—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000199	0.00049	CcSEcCtD
Perindopril—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000489	CcSEcCtD
Perindopril—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000198	0.000489	CcSEcCtD
Perindopril—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000488	CcSEcCtD
Perindopril—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000487	CcSEcCtD
Perindopril—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000198	0.000487	CcSEcCtD
Perindopril—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000486	CcSEcCtD
Perindopril—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000486	CcSEcCtD
Perindopril—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000486	CcSEcCtD
Perindopril—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000484	CcSEcCtD
Perindopril—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000483	CcSEcCtD
Perindopril—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000196	0.000483	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000482	CcSEcCtD
Perindopril—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000196	0.000482	CcSEcCtD
Perindopril—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.00048	CcSEcCtD
Perindopril—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000195	0.00048	CcSEcCtD
Perindopril—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00048	CcSEcCtD
Perindopril—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000195	0.00048	CcSEcCtD
Perindopril—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000479	CcSEcCtD
Perindopril—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000194	0.000479	CcSEcCtD
Perindopril—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.000478	CcSEcCtD
Perindopril—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000194	0.000477	CcSEcCtD
Perindopril—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000477	CcSEcCtD
Perindopril—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000475	CcSEcCtD
Perindopril—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000193	0.000475	CcSEcCtD
Perindopril—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000192	0.000474	CcSEcCtD
Perindopril—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000474	CcSEcCtD
Perindopril—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000474	CcSEcCtD
Perindopril—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000473	CcSEcCtD
Perindopril—Rash—Stavudine—acquired immunodeficiency syndrome	0.000192	0.000473	CcSEcCtD
Perindopril—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000192	0.000473	CcSEcCtD
Perindopril—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000192	0.000473	CcSEcCtD
Perindopril—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000472	CcSEcCtD
Perindopril—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000472	CcSEcCtD
Perindopril—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000191	0.000472	CcSEcCtD
Perindopril—Headache—Stavudine—acquired immunodeficiency syndrome	0.000191	0.00047	CcSEcCtD
Perindopril—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000191	0.00047	CcSEcCtD
Perindopril—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000191	0.000469	CcSEcCtD
Perindopril—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000469	CcSEcCtD
Perindopril—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00019	0.000469	CcSEcCtD
Perindopril—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000469	CcSEcCtD
Perindopril—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00019	0.000468	CcSEcCtD
Perindopril—Rash—Abacavir—acquired immunodeficiency syndrome	0.000189	0.000466	CcSEcCtD
Perindopril—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000189	0.000466	CcSEcCtD
Perindopril—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000466	CcSEcCtD
Perindopril—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000466	CcSEcCtD
Perindopril—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000465	CcSEcCtD
Perindopril—Headache—Abacavir—acquired immunodeficiency syndrome	0.000188	0.000463	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000462	CcSEcCtD
Perindopril—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000187	0.000462	CcSEcCtD
Perindopril—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000187	0.000461	CcSEcCtD
Perindopril—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000459	CcSEcCtD
Perindopril—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000458	CcSEcCtD
Perindopril—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000457	CcSEcCtD
Perindopril—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000456	CcSEcCtD
Perindopril—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000185	0.000456	CcSEcCtD
Perindopril—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000455	CcSEcCtD
Perindopril—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.000455	CcSEcCtD
Perindopril—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000453	CcSEcCtD
Perindopril—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000453	CcSEcCtD
Perindopril—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000452	CcSEcCtD
Perindopril—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000452	CcSEcCtD
Perindopril—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000452	CcSEcCtD
Perindopril—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000451	CcSEcCtD
Perindopril—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.00045	CcSEcCtD
Perindopril—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000448	CcSEcCtD
Perindopril—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000182	0.000447	CcSEcCtD
Perindopril—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000446	CcSEcCtD
Perindopril—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.000446	CcSEcCtD
Perindopril—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000181	0.000446	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000445	CcSEcCtD
Perindopril—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000444	CcSEcCtD
Perindopril—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000441	CcSEcCtD
Perindopril—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000441	CcSEcCtD
Perindopril—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000178	0.000439	CcSEcCtD
Perindopril—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000438	CcSEcCtD
Perindopril—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000438	CcSEcCtD
Perindopril—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000437	CcSEcCtD
Perindopril—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.000436	CcSEcCtD
Perindopril—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000435	CcSEcCtD
Perindopril—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000177	0.000435	CcSEcCtD
Perindopril—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000435	CcSEcCtD
Perindopril—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000434	CcSEcCtD
Perindopril—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000434	CcSEcCtD
Perindopril—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000434	CcSEcCtD
Perindopril—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000433	CcSEcCtD
Perindopril—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000433	CcSEcCtD
Perindopril—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000175	0.000431	CcSEcCtD
Perindopril—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00043	CcSEcCtD
Perindopril—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000429	CcSEcCtD
Perindopril—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000424	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000424	CcSEcCtD
Perindopril—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000421	CcSEcCtD
Perindopril—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000171	0.000421	CcSEcCtD
Perindopril—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000421	CcSEcCtD
Perindopril—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000418	CcSEcCtD
Perindopril—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000418	CcSEcCtD
Perindopril—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000417	CcSEcCtD
Perindopril—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.000417	CcSEcCtD
Perindopril—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000415	CcSEcCtD
Perindopril—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000415	CcSEcCtD
Perindopril—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000415	CcSEcCtD
Perindopril—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000415	CcSEcCtD
Perindopril—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000414	CcSEcCtD
Perindopril—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.000411	CcSEcCtD
Perindopril—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000411	CcSEcCtD
Perindopril—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.000411	CcSEcCtD
Perindopril—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.00041	CcSEcCtD
Perindopril—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.000409	CcSEcCtD
Perindopril—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000405	CcSEcCtD
Perindopril—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000405	CcSEcCtD
Perindopril—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000403	CcSEcCtD
Perindopril—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000402	CcSEcCtD
Perindopril—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000402	CcSEcCtD
Perindopril—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000401	CcSEcCtD
Perindopril—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000401	CcSEcCtD
Perindopril—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000401	CcSEcCtD
Perindopril—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000401	CcSEcCtD
Perindopril—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000399	CcSEcCtD
Perindopril—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000398	CcSEcCtD
Perindopril—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000398	CcSEcCtD
Perindopril—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000393	CcSEcCtD
Perindopril—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000392	CcSEcCtD
Perindopril—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000388	CcSEcCtD
Perindopril—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000388	CcSEcCtD
Perindopril—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000157	0.000387	CcSEcCtD
Perindopril—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000386	CcSEcCtD
Perindopril—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000386	CcSEcCtD
Perindopril—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000386	CcSEcCtD
Perindopril—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000384	CcSEcCtD
Perindopril—Rash—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000382	CcSEcCtD
Perindopril—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000155	0.000382	CcSEcCtD
Perindopril—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000381	CcSEcCtD
Perindopril—Headache—Indinavir—acquired immunodeficiency syndrome	0.000154	0.00038	CcSEcCtD
Perindopril—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.000379	CcSEcCtD
Perindopril—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.000375	CcSEcCtD
Perindopril—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00037	CcSEcCtD
Perindopril—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000368	CcSEcCtD
Perindopril—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000368	CcSEcCtD
Perindopril—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000364	CcSEcCtD
Perindopril—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000364	CcSEcCtD
Perindopril—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.000363	CcSEcCtD
Perindopril—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000361	CcSEcCtD
Perindopril—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.000361	CcSEcCtD
Perindopril—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000146	0.00036	CcSEcCtD
Perindopril—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000359	CcSEcCtD
Perindopril—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000359	CcSEcCtD
Perindopril—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.00035	CcSEcCtD
Perindopril—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000349	CcSEcCtD
Perindopril—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000347	CcSEcCtD
Perindopril—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000346	CcSEcCtD
Perindopril—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000345	CcSEcCtD
Perindopril—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000345	CcSEcCtD
Perindopril—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000344	CcSEcCtD
Perindopril—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.00034	CcSEcCtD
Perindopril—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000335	CcSEcCtD
Perindopril—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000334	CcSEcCtD
Perindopril—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000334	CcSEcCtD
Perindopril—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000329	CcSEcCtD
Perindopril—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000326	CcSEcCtD
Perindopril—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000323	CcSEcCtD
Perindopril—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000322	CcSEcCtD
Perindopril—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00032	CcSEcCtD
Perindopril—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000319	CcSEcCtD
Perindopril—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000319	CcSEcCtD
Perindopril—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000318	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000127	0.0125	CbGpPWpGaD
Perindopril—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00031	CcSEcCtD
Perindopril—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000308	CcSEcCtD
Perindopril—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000308	CcSEcCtD
Perindopril—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000307	CcSEcCtD
Perindopril—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000306	CcSEcCtD
Perindopril—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000301	CcSEcCtD
Perindopril—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000296	CcSEcCtD
Perindopril—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000294	CcSEcCtD
Perindopril—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000293	CcSEcCtD
Perindopril—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000292	CcSEcCtD
Perindopril—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.00029	CcSEcCtD
Perindopril—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000277	CcSEcCtD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	9.67e-05	0.00951	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	9.67e-05	0.00951	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.42e-05	0.00828	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	8.37e-05	0.00823	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	6.35e-05	0.00624	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	6.35e-05	0.00624	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	6.17e-05	0.00607	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	6.04e-05	0.00594	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	5.03e-05	0.00494	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.66e-05	0.00459	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TAT—acquired immunodeficiency syndrome	4.41e-05	0.00434	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AGPS—acquired immunodeficiency syndrome	3.75e-05	0.00369	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	3.73e-05	0.00367	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	3.32e-05	0.00326	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.55e-05	0.00251	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	2.42e-05	0.00238	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.37e-05	0.00233	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.15e-05	0.00212	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	1.83e-05	0.0018	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.73e-05	0.0017	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.19e-05	0.00117	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.01e-06	0.000788	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALB—acquired immunodeficiency syndrome	7.69e-06	0.000756	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.75e-06	0.000369	CbGpPWpGaD
